Psilocybin: From Psychiatric Pariah to Perceived Panacea
American Journal of Psychiatry – January 01, 2025
Source: OpenAlex
Summary
Psilocybin, a potent hallucinogen derived from chemical synthesis and alkaloids, holds significant promise for Psychiatry. While not yet a proven panacea medicine, its potential as a psychotherapeutic tool is driving diverse academic research themes in Psychedelics and Drug Studies. However, current evidence is insufficient for recommending it as a mainstream medicine. Future trials require larger, more diverse samples to establish efficacy, optimize dosing, and improve blinding. This will clarify its role, moving it beyond its historical status as a pariah group substance, and integrate it into Psychology's therapeutic arsenal.
Abstract
The evidence is currently insufficient to recommend psilocybin with PST as a psychiatric treatment. Additional rigorously designed clinical trials are needed to definitively establish efficacy in larger and more diverse samples, address dosing considerations, improve blinding, and provide information on mechanisms of action and moderators of clinical response. Head-to-head comparisons with other evidence-based treatments will better inform the potential future role of psilocybin with PST in the treatment of major psychiatric disorders.